Oct. 15, 2013 – Now that Sunshine Act implementation is underway, pharmaceutical companies need to tighten up their reporting policies and procedures and help to educate and inform healthcare professionals (HCPs) before the federal database goes live in September 2014, according to speakers presenting at the recent Coalition for Healthcare Communication D.C. meeting. The Coalition […]
Read moreTag: Angel
AngelCoalition Leaders Highlight Agency/Publisher Challenges To Ensure Accuracy and Understanding of Sunshine Reports
June 19, 2013 – The pharmaceutical industry needs to put strategies in place now to help them overcome the significant obstacles it will face as the Physician Payment Sunshine provisions of the Affordable Care Act kick in over the next year, according to speakers at a June 18 Webinar co-sponsored by the Coalition for Healthcare […]
Read moreCoalition’s Kamp, Angel To Speak at June 18 Sunshine Act Webinar
June 4, 2013 – John Kamp, Coalition for Healthcare Communication Executive Director, and Jack Angel, Executive Director of the Coalition’s Education Foundation, will be speaking at an upcoming Sunshine Act Webinar: “Preparing for Physician Payment Sunshine Act Implementation: A Primer for Publishers and Agencies.” The June 18 Webinar, hosted by the Coalition and the Association […]
Read moreCoalition: Educational Materials Should Be Excluded from Sunshine Reporting
April 22, 2013 – In April 18 comments to the Centers for Medicare & Medicaid Services (CMS) the Coalition for Healthcare Communication (CHC) recommended that the agency address key concerns before moving forward with planned FAQs regarding compliance with and implementation of the Sunshine Act final rules. CHC believes that its suggestions “will advance the […]
Read moreJ&J Settlement Restricts Marketing Distribution of Journal Article Reprints
Sept. 10, 2012 – A recent settlement between Johnson & Johnson/Janssen and multiple states to resolve claims that the company promoted unapproved uses for its antipsychotic drugs Risperdal and Invega is significant not only because J&J will pay $181 million but also because, among several provisions, the settlement restricts J&J’s ability to distribute reprints of […]
Read moreCall for Industry Comments: Proposed FDA Study on “Corrective” DTC TV Advertising
March 26, 2012 – Note to Industry Leaders The Coalition for Healthcare Communication needs your input on a study FDA is planning to conduct regarding corrective DTC television advertising. In the recent past, FDA has used this enforcement tool only sparingly, most notably as part of a Warning Letter involving contraceptives. Our primary concern is […]
Read moreGovernment, Industry and Educators Are Called to Action on a Looming Health Crisis
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Nov. 14, 2011 — In response to Opioid prescription drug misuse in this country, the FDA recently released a draft “blueprint” on the basic elements to be included in REMS (Risk Evaluation and Mitigation Strategies) educational programs required of the manufacturers by the FDA. […]
Read more